| Spontaneous assembly of subnanometre-ordered domains in the ligand shell of monolayer-protected nanoparticles AM Jackson, JW Myerson, F Stellacci Nature materials 3 (5), 330-336, 2004 | 679 | 2004 |
| Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude JS Brenner, DC Pan, JW Myerson, OA Marcos-Contreras, CH Villa, ... Nature communications 9 (1), 2684, 2018 | 289 | 2018 |
| Microphysiological engineering of self-assembled and perfusable microvascular beds for the production of vascularized three-dimensional human microtissues J Paek, SE Park, Q Lu, KT Park, M Cho, JM Oh, KW Kwon, Y Yi, JW Song, ... ACS nano 13 (7), 7627-7643, 2019 | 170 | 2019 |
| The role of nanostructure in the wetting behavior of mixed-monolayer-protected metal nanoparticles A Centrone, E Penzo, M Sharma, JW Myerson, AM Jackson, N Marzari, ... Proceedings of the National Academy of Sciences 105 (29), 9886-9891, 2008 | 137 | 2008 |
| Nanoparticle properties modulate their attachment and effect on carrier red blood cells DC Pan, JW Myerson, JS Brenner, PN Patel, AC Anselmo, S Mitragotri, ... Scientific Reports 8 (1), 1615, 2018 | 119 | 2018 |
| Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier OA Marcos-Contreras, CF Greineder, RY Kiseleva, H Parhiz, LR Walsh, ... Proceedings of the National Academy of Sciences 117 (7), 3405-3414, 2020 | 118 | 2020 |
| Gadolinium‐modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging AM Neubauer, J Myerson, SD Caruthers, FD Hockett, PM Winter, J Chen, ... Magnetic Resonance in Medicine: An Official Journal of the International …, 2008 | 116 | 2008 |
| Thrombin‐inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis J Myerson, L He, G Lanza, D Tollefsen, S Wickline Journal of Thrombosis and Haemostasis 9 (7), 1292-1300, 2011 | 107 | 2011 |
| Rapamycin nanoparticles target defective autophagy in muscular dystrophy to enhance both strength and cardiac function KP Bibee, YJ Cheng, JK Ching, JN Marsh, AJ Li, RM Keeling, ... The FASEB Journal 28 (5), 2047, 2014 | 86 | 2014 |
| Flexible nanoparticles reach sterically obscured endothelial targets inaccessible to rigid nanoparticles JW Myerson, B Braender, O Mcpherson, PM Glassman, RY Kiseleva, ... Advanced Materials 30 (32), 1802373, 2018 | 81 | 2018 |
| Targeting drug delivery in the vascular system: Focus on endothelium PM Glassman, JW Myerson, LT Ferguson, RY Kiseleva, VV Shuvaev, ... Advanced drug delivery reviews 157, 96-117, 2020 | 79 | 2020 |
| Non-affinity factors modulating vascular targeting of nano-and microcarriers JW Myerson, AC Anselmo, Y Liu, S Mitragotri, DM Eckmann, ... Advanced drug delivery reviews 99, 97-112, 2016 | 73 | 2016 |
| Programmable nanoparticle functionalization for in vivo targeting H Pan, JW Myerson, L Hu, JN Marsh, K Hou, MJ Scott, JS Allen, G Hu, ... The FASEB Journal 27 (1), 255, 2013 | 71 | 2013 |
| Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation Nature Nanotechnology, 2021 | 62* | 2021 |
| Unintended effects of drug carriers: Big issues of small particles H Parhiz, M Khoshnejad, JW Myerson, E Hood, PN Patel, JS Brenner, ... Advanced drug delivery reviews 130, 90-112, 2018 | 57 | 2018 |
| Added to pre-existing inflammation, mRNA-lipid nanoparticles induce inflammation exacerbation (IE) H Parhiz, JS Brenner, PN Patel, TE Papp, H Shahnawaz, Q Li, R Shi, ... Journal of Controlled Release 344, 50-61, 2022 | 54 | 2022 |
| Thrombin-targeted liposomes establish a sustained localized anticlotting barrier against acute thrombosis RU Palekar, JW Myerson, PH Schlesinger, JE Sadler, H Pan, SA Wickline Molecular Pharmaceutics 10 (11), 4168-4175, 2013 | 45 | 2013 |
| Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis RU Palekar, AP Jallouk, JW Myerson, H Pan, SA Wickline Arteriosclerosis Thrombosis and Vascular Biology, 2016 | 43 | 2016 |
| Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain OA Marcos-Contreras, JS Brenner, RY Kiseleva, V Zuluaga-Ramirez, ... Journal of controlled release 301, 54-61, 2019 | 39 | 2019 |
| Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions JS Brenner, K Bhamidipati, PM Glassman, N Ramakrishnan, D Jiang, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (4), 1495-1506, 2017 | 36 | 2017 |
